775 Fed.Appx. 51 (3rd Cir. 2019), 18-2474, Vizirgianakis v. Aeterna Zentaris, Inc.

Docket Nº:18-2474
Citation:775 Fed.Appx. 51
Opinion Judge:SILER, Circuit Judge.
Party Name:Gregory VIZIRGIANAKIS; Phong Thomas Dinh; Jamshid Khodavandi v. AETERNA ZENTARIS, INC.; Juergen Engel; David A. Dodd; Paul Blake; Nicholas J. Pelliccione Appellants
Attorney:James E. Cecchi, Esq., Donald A. Ecklund, Esq., Carella Byrne Cecchi Olstein Brody & Agnello, Roseland, NJ, Christopher R. Fallon, Esq., Kevin Ruf, Esq., Kara M. Wolke, Esq., Glancy Prongay & Murray, Los Angeles, CA, Laurence M. Rosen, Esq., South Orange, NJ, for Plaintiffs-Appellees Austin A. Ev...
Judge Panel:Before: CHAGARES, HARDIMAN, and SILER, JR., Circuit Judges
Case Date:May 30, 2019
Court:United States Courts of Appeals, Court of Appeals for the Third Circuit
 
FREE EXCERPT

Page 51

775 Fed.Appx. 51 (3rd Cir. 2019)

Gregory VIZIRGIANAKIS; Phong Thomas Dinh; Jamshid Khodavandi

v.

AETERNA ZENTARIS, INC.; Juergen Engel; David A. Dodd; Paul Blake; Nicholas J. Pelliccione Appellants

No. 18-2474

United States Court of Appeals, Third Circuit

May 30, 2019

Submitted under Third Circuit L.A.R. 34.1(a) April 2, 2019

NOT PRECEDENTIAL

Editorial Note:

This opinion is not regarded as Precedents which bind the court under Third Circuit Internal Operating Procedure Rule 5.7. (See Federal Rule of Appellate Procedure Rule 32.1)

On Appeal from the United States District Court for the District of New Jersey (No. 3:14-cv-07081), District Judge: Hon. Peter G. Sheridan

James E. Cecchi, Esq., Donald A. Ecklund, Esq., Carella Byrne Cecchi Olstein Brody & Agnello, Roseland, NJ, Christopher R. Fallon, Esq., Kevin Ruf, Esq., Kara M. Wolke, Esq., Glancy Prongay & Murray, Los Angeles, CA, Laurence M. Rosen, Esq., South Orange, NJ, for Plaintiffs-Appellees

Austin A. Evans, Esq., King & Spalding, Atlanta, GA, Felice B. Galant, Esq., Norton Rose Fulbright, New York, NY, Gerard G. Pecht, Esq., Norton Rose Fulbright, Houston, TX, for Defendant-Appellant Juergen Engel

Jeffrey S. Bucholtz, Esq., Joshua N. Mitchell, Esq., King & Spalding, Washington, DC, Austin A. Evans, Esq., Brandon Keel, Esq., B. Warren Pope, Esq., Michael R. Smith, Esq., King & Spalding, Atlanta, GA, for Defendants-Appellants Nicholas J. Pelliccione

Before: CHAGARES, HARDIMAN, and SILER, JR.,[*] Circuit Judges

OPINION[**]

SILER, Circuit Judge.

Page 52

Pursuant to Federal Rule of Civil Procedure 23(f), defendants Aeterna Zentaris, Inc., and its named former employees,1 appeal the district court’s order granting class certification in this securities action. We will affirm the decision of the district court.

I.

We write for the parties and relate only the necessary facts. In 2009, the biopharmaceutical company Aeterna acquired the rights to AEZS-130, a drug in development it sought to have approved for commercialization by the Food and Drug Administration ("FDA"). To this end, Aeterna agreed to continue an ongoing study of the drug according to the terms of a Special Protocol Assessment ("SPA"), an agreement between Aeterna and the FDA regarding how the study should be completed to show the drug’s safety and efficacy.

According to the complaint, Aeterna issued numerous press releases and other statements indicating that the study showed the drug was effective in accordance with the protocol agreed to...

To continue reading

FREE SIGN UP